WASHINGTON — The White Home has drafted legislative textual content for its drug pricing coverage, and officers are within the strategy of sharing it with greater than a dozen main pharmaceutical firms, in accordance with folks accustomed to the conferences.
The legislative textual content, in accordance with a White Home official, carefully follows the outlines of the voluntary offers the administration made with pharma firms. The draft features a coverage that might permit medicine bought in money to rely towards a affected person’s deductible.
The Trump administration’s push for drug value laws is a component of a bigger effort to get well being reforms signed into regulation. The president’s give attention to his affordability agenda in an election 12 months has heightened the profile of the hassle.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
View All Plans

